Social News
Written by: Hu Jiaxin
2021-04-02 10:39
The last update date: 2021-04-02 10:39
Two batches of BioNTech's new crown pneumonia vaccine were defective due to bottle caps. After investigation, the German pharmaceutical factory said there was a problem with the crimping of the metal ring of the vaccine bottle.
Cui Junming, president of the Hong Kong Institute of Hospital Pharmacists, said on the Hong Kong and Taiwan program "Millenniums" this morning that under normal circumstances, vaccines will be packaged to evaluate the reaction of different gases and temperatures to the metal ring.
He pointed out that the rubber stopper of the vaccine bottle will shrink due to the low temperature. If the test is rigorous and the metal ring is tightly crimped, there will be no gaps and gas infiltration; he thinks that the drug factory should recall the problematic batch of vaccine and re-ship Over a million doses arrived in Hong Kong.
Cui Junming said that the pharmaceutical factory has to be responsible and apologize for negligence in handling vaccines.
(Profile picture)
Cui Junming said that although the vaccine has a problem with its bottle cover, it is difficult for bacteria to enter and breed when stored at minus 70 degrees Celsius and thawed at 2 to 8 degrees Celsius. Bacteria can only multiply at 30 to 35 degrees Celsius.
He continued that the incident caused 180,000 citizens and those who had already made appointments to delay their injections, and that the pharmaceutical factory was responsible and apologized for negligence in handling the vaccine.
He pointed out that the vaccine involved has no safety risks and pollution, and theoretically it can be vaccinated, but considering the effective date of the vaccine and the public’s confidence in the vaccine, he believes that the pharmaceutical factory should recall the two batches of vaccines and ship another million doses to Hong Kong.
Fubitai Vaccine|The second batch of only 300,000 doses arrives in Hong Kong, pharmacists expect that Fosun refrigerators will be "full"
Fubitel|300,000 doses arriving in Hong Kong are not enough to meet the affected citizens, Baxter is responsible for supplying Hong Kong vaccines
Fubitai|The 180,000 affected citizens will resume vaccination next Monday to update their vaccination time SMS
01News
New Coronary Vaccine Vaccine New Coronary Pneumonia